Read More

Combangio, Inc., A Wholly Owned Subsidiary Of Kala Pharmaceuticals, Awarded $15M By California Institute For Regenerative Medicine To Support Ongoing KPI-012 Program For The Treatment Of Persistent Corneal Epithelial Defect

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today

KALA

Read More

Par Pacific Announces $90M Significant Investment In Hawaii Renewable Fuels Production; This Project Is Expected To Be Completed For Less Than $1.50 Per Gallon Of Annual Operating Capacity And Is Expected To Be Commissioned In 2025

Par Pacific Holdings, Inc. (NYSE:PARR) ("Par Pacific" or the "Company") today announced it plans to invest approximately $90 million to develop the state's largest liquid renewable fuels manufacturing facility at its

PARR

Read More

First Solar, Inc. Announced An Agreement To Supply 2 GW DC Of Advanced, Responsibly Produced Thin Film Photovoltaic Solar Modules To Leeward Renewable Energy. The Deal Is Expected To See First Solar Deliver The Modules In 2026 And 2027.

Responsibly produced ultra-low carbon thin film modules to power US projects, with deliveries in 2026 and 2027First Solar, Inc. (NASDAQ:FSLR) today announced an agreement to supply 2 gigawatts (GW)DC of advanced,

FSLR